Business Intelligence
The increase represents a substantial impact, especially given the use of many high-cost drugs, the report says. The firm also points to biosimilars as opportunity to thwart spending.
The entire ecosystem is changing, forcing smart CIOs to keep pace or face significant disruption.
The organizations use voice recognition and artificial intelligence to build interactive reports that include more elements than simply what a clinician adds, such as images, charts and graphs.
The growth in expenses is attributed largely to rising prices for emergency department visits, surgery and prescription drugs.
Knee-deep in the integration process, Robert Musslewhite says the company will be focusing on analytics, best practices, research and broadening its portfolio of services.
The analysis cited uncertainty surrounding the tax and healthcare bills as one of the major contributors to the dip, along with a tight labor market.
Meanwhile, prescription drug prices jumped 1 percent after a 0.6 percent rise late last year.
Since 2008, executives and employees of the companies have invested more than $30 million in the three real estate investment trusts.
HIMSS CEO Hal Wolf says the culture of "do no harm" is contending with the culture of innovation and "fail fast."
Expert says transactions are being driven chiefly by strategic imperatives, less so by financial drivers.